Skip to main content
. 2012 Jul 16;7(7):e40748. doi: 10.1371/journal.pone.0040748

Figure 1. Effects of the PVN microinjection of different doses of ET-1 (0,0.1,1 and 10 pmol) on the baseline RSNA and MAP (A) and CSAR (B).

Figure 1

The CSAR was evaluated by the RSNA and MAP responses to epicardial application of capsaicin. Values are mean ± SE. *P<0.05 compared with control. n = 6 for each group.